Bilici, A. Et Al. 2022. Pazopanib in metastatic soft tissue sarcoma (STS): Results of a multi-institutional observational study.. JOURNAL OF CLINICAL ONCOLOGY , vol.40, no.16 .

Bilici, A., Koca, S., Karaagac, M., Eraslan, E., Ocak, B., Aydin, S. G., ... Goksu, S. S.(2022). Pazopanib in metastatic soft tissue sarcoma (STS): Results of a multi-institutional observational study.. JOURNAL OF CLINICAL ONCOLOGY , vol.40, no.16.

Bilici, Ahmet Et Al. "Pazopanib in metastatic soft tissue sarcoma (STS): Results of a multi-institutional observational study.," JOURNAL OF CLINICAL ONCOLOGY , vol.40, no.16, 2022

Bilici, Ahmet Et Al. "Pazopanib in metastatic soft tissue sarcoma (STS): Results of a multi-institutional observational study.." JOURNAL OF CLINICAL ONCOLOGY , vol.40, no.16, 2022

Bilici, A. Et Al. (2022) . "Pazopanib in metastatic soft tissue sarcoma (STS): Results of a multi-institutional observational study.." JOURNAL OF CLINICAL ONCOLOGY , vol.40, no.16.

@article{article, author={Ahmet Bilici Et Al. }, title={Pazopanib in metastatic soft tissue sarcoma (STS): Results of a multi-institutional observational study.}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2022}